USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Novel Inhaler Devices and Formulations are Impetuses for Growth
The research service assesses marketed and investigational products, as well as combination regimens, for asthma and chronic obstructive pulmonary disease (COPD). Segmentation by drug class is provided along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and epidemiology. The marketed and pipeline products are broadly segmented into bronchodilators, anti-inflammatories, and combination therapies of current global interest. Novel inhaler devices, formulations, and anti-inflammatories are key drivers for the market.
Key Findings
Key Findings—Asthma
Key Findings—COPD
Overview of Product Launches and Pipeline Development
Key Companies to Watch
CEO’s Perspective
Methodology and Scope
Market Overview—Segmentation
Market Overview—Definitions
Prevalence of Asthma by Country/Region
Prevalence of COPD by Country/Region
Asthma Therapeutics Market—Marketed and Pipeline Products
Asthma Therapeutics Market—Marketed and Pipeline Products (continued)
Asthma Therapeutics Market—Key Marketed Product Synopsis
Asthma Therapeutics Market—Key Marketed Product Synopsis (continued)
Asthma Therapeutics Market—Key Pipeline Product Synopsis
Asthma Therapeutics Market—Key Pipeline Product Synopsis (continued)
COPD Therapeutics Market—Marketed and Pipeline Products
COPD Therapeutics Market—Marketed and Pipeline Products (continued)
COPD Therapeutics Market—Key Marketed Product Synopsis
COPD Therapeutics Market—Key Marketed Product Synopsis (continued)
COPD Therapeutics Market—Key Pipeline Product Synopsis
COPD Therapeutics Market—Key Pipeline Product Synopsis (continued)
Total Asthma and COPD Therapeutics Market—Projected Launch Timeline for Key Pipeline Drugs
Pivotal Phase 3 Trials
Estimated Product Launch Timeline—Striverdi Respimat for Asthma and COPD by Boehringer Ingelheim
Estimated Product Launch Timeline—Quilizumab for Asthma by Genentech
Estimated Product Launch Timeline—DuoResp Spiromax for Asthma and COPD by Teva Pharmaceuticals
Estimated Product Launch Timeline—Incruse Ellipta (umeclidinium) for COPD by GSK
Estimated Product Launch Timeline—Benralizumab for Asthma by AstraZeneca
Patent Expiration Timeline
Seebri Breezhaler by Novartis
Advair/Seretide by GSK
Xolair by Genentech and Novartis
Asmanex Twisthaler by Merck & Co.
Spiriva by Boehringer Ingelheim
AirFlu Sal/Forspiro by Sandoz (Novartis)
Incruse Ellipta by GSK
Benralizumab by AstraZeneca
Bosatria by GSK
PT003 by Pearl Therapeutics (AstraZeneca)
Conclusions
Legal Disclaimer
Decision Support Database—Global Prevalence of Smokers
Decision Support Database—Global Prevalence of Smokers (continued)
Decision Support Database—Population with COPD
Decision Support Database—Population with COPD (continued)
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related industry research
17 Sep 2026 | Asia Pacific | Frost Radar
Frost Radar™: Facility Management in Malaysia, 2026
Malaysia's facility management (FM) market is transitioning from labor-intensive, compliance-driven service delivery to technology-enabled, outcome-oriented, and sustainability-integrated operating models. Competitive differentiation increasingly depends on providers’ ability to combine integrated F...
17 Sep 2026 | Global | Market Research
Growth Opportunities in the Western Europe Consumer eSIM Market, 2026–2029
The consumer eSIM market in Western Europe is growing steadily, supported by the rising availability of eSIM-capable devices, particularly smartphones, and expanding travel-related use cases. However, commercialization has yet to translate into mass adoption. Despite Apple’s global launch of an eSIM...
17 Sep 2026 | Asia Pacific | Frost Radar
Frost Radar™: ASEAN Warehouse Automation System Providers, 2026
Warehouse automation has moved from a discretionary capital project to a core operating capability. ASEAN operators are redesigning fulfillment networks around smaller orders, shorter delivery windows, broader stock keeping unit (SKU) ranges, and sharper demand volatility. Manual operations remain v...
16 Sep 2026 | North America | Customer Research
US Automotive Technicians’ Choice Survey, 2025
The 2025 US Automotive Technicians’ Choice study is an insightful voice-of-customer survey that highlights the tool preferences of automotive aftermarket service technicians. The survey of 400 automotive technicians across the United States used a combination of computer-assisted telephone and compu...
16 Sep 2026 | Global | Market Research
Apple Performance Tracker, Q1 2026
This Frost & Sullivan tracker provides metrics on Apple's quarterly performance (for both unit sales and revenues) for iPads, iPhones, Macs, and other products, such as iPods, Apple TVs, Beats Electronics, and Apple-branded and third-party accessories. It includes historical quarterly data for all t...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Sriram Radhakrishnan |
| WIP Number | MA2A-01-00-00-00 |
| Is Prebook | No |